Book Cover
Home  |   Healthcare   |  Stem Cell Media Market

Stem Cell Media Market Size, Share, Growth, and Industry Analysis, By Type (Pluripotent Stem Cell Culture,Hematopoietic Stem Cell Culture,Mesenchymal Stem Cell Culture,OtherS), By Application (Scientific Research,Industrial Production,Other), Regional Insights and Forecast to 2035

Trust Icon
1000+
GLOBAL LEADERS TRUST US

Stem Cell Media Market Overview

The global Stem Cell Media Market is forecast to expand from USD 545.14 million in 2026 and is expected to reach USD 1210.84 million by 2035, growing at a CAGR of 9.27% over the forecast period.

The Stem Cell Media Market is expanding as biotechnology companies, pharmaceutical developers, and academic laboratories increasingly rely on specialized formulations for controlled stem cell maintenance, expansion, and differentiation. Pluripotent Stem Cell Culture represents approximately 41% of the supplied product distribution, reflecting extensive research into regenerative medicine, disease modeling, and cellular development. Manufacturers are improving chemically defined formulations, serum-free alternatives, nutrient consistency, and compatibility with automated laboratory systems. Growing demand for reproducible cellular performance is encouraging organizations to strengthen quality-control practices. The supply chain increasingly emphasizes validated raw materials, temperature-controlled logistics, growth-factor availability, and dependable manufacturing processes to support advanced cell culture research.

The United States Stem Cell Media Market benefits from established biotechnology infrastructure, extensive stem cell research, pharmaceutical innovation, and growing investment in regenerative medicine. North America represents approximately 36% of the supplied global market distribution, supported by academic laboratories, biotechnology companies, and advanced therapeutic research centers. American organizations increasingly prefer defined and serum-free formulations that support reproducibility across different cell culture protocols. Pluripotent, hematopoietic, and mesenchymal stem cell research creates demand for specialized nutrients, growth factors, and culture supplements. Manufacturers are developing scalable production capabilities and improved quality documentation. Reliable supply chains, laboratory automation, and technical support are increasingly important for maintaining consistent research performance.

Global Stem Cell Media Market Size, 2035 (USD Million)

Get Comprehensive Insights into the Market’s Size and Growth Trends

downloadDownload FREE Sample

Key Findings

  • Key Market Driver: Expansion of regenerative medicine, disease modeling, and advanced cellular research is supporting specialty media adoption, with Scientific Research representing approximately 61% of the supplied application distribution.
  • Major Market Restraint: Complex formulations, temperature-sensitive components, and strict handling requirements continue limiting adoption, with quality and storage considerations influencing approximately 24% of purchasing decisions.
  • Emerging Trends: Chemically defined, serum-free, and application-specific formulations are transforming stem cell culture workflows, with advanced defined media representing approximately 43% of newly evaluated culture systems.
  • Regional Leadership: North America maintains the leading position in the Stem Cell Media Market with approximately 36% regional share, supported by extensive biotechnology research and therapeutic development.
  • Competitive Landscape: STEMCELL Technologies leads the supplied competitive assessment with approximately 10% market share, supported by specialized culture formulations, extensive research applications, and established laboratory relationships.
  • Market Segmentation: Pluripotent Stem Cell Culture dominates the supplied product segmentation with approximately 41% market share, reflecting substantial demand from cellular differentiation and regenerative research.
  • Recent Development: Lonza introduced a Media Development Lab in March 2026 to improve formulation optimization and manufacturing scalability, supporting the 27% customization priority identified in the supplied market analysis.

The Stem Cell Media Market is increasingly influenced by chemically defined, serum-free, and cell-type-specific formulations designed to improve reproducibility. Advanced defined media represent approximately 43% of newly evaluated culture workflows in the supplied market analysis. Researchers increasingly seek standardized nutritional environments capable of supporting consistent stem cell expansion, maintenance, and differentiation. Pluripotent Stem Cell Culture is benefiting from formulations that support controlled cellular characteristics during repeated passages. Hematopoietic and mesenchymal stem cell research also requires specialized nutrient combinations and growth-supporting components. Manufacturers are investing in formulation consistency, raw-material qualification, and improved laboratory documentation. These developments strengthen demand for reliable products across regenerative medicine and cellular research programs.

Another important trend involves automated cell culture, scalable media manufacturing, and improved supply-chain reliability. Formulation customization influences approximately 27% of the supplied new-product evaluations, reflecting increasing demand for specialized culture environments. Laboratories are integrating automated dispensing, imaging, controlled incubation, and standardized feeding procedures into advanced cellular workflows. Industrial users increasingly require media suitable for larger processing volumes and consistent performance between manufacturing batches. Manufacturers are introducing ready-to-use formulations, concentrated supplements, and improved packaging configurations. Product traceability and quality documentation are becoming increasingly important as biotechnology organizations move from research experimentation toward structured production processes. These developments support more efficient media preparation and laboratory reproducibility.

Stem Cell Media Market Dynamics

Driver

""Growing regenerative medicine and cellular research activities accelerate specialized culture media demand.""

The primary driver of the Stem Cell Media Market is expanding scientific research involving regenerative medicine, cellular development, disease modeling, and advanced therapeutic technologies. Scientific Research accounts for approximately 61% of the supplied application distribution, demonstrating its importance to market demand. Stem cell experiments require precisely controlled nutritional environments because cellular growth and differentiation depend on suitable culture conditions. Researchers increasingly use specialized formulations to support repeatable results across different experiments. Demand is particularly strong for media compatible with pluripotent and adult stem cell models. Growing interest in cell-based treatments and advanced biological investigation supports continued investment in specialized media products.

Increasing sophistication in biotechnology research provides another important growth driver as laboratories adopt more complex cellular models and experimental procedures. Pluripotent Stem Cell Culture represents approximately 41% of the supplied product distribution, reflecting its broad use in differentiation studies and disease modeling. Researchers may require different formulations during cell maintenance, expansion, and specialized differentiation stages. Reliable media can help maintain suitable culture conditions and reduce unnecessary experimental variability. Manufacturers are responding with defined compositions, improved supplement systems, and detailed product documentation. Increasing collaboration between research institutions and biotechnology companies also supports demand for standardized formulations that can be used across multiple laboratories.

Restraint

""Complex formulations and specialized handling requirements increase laboratory operating challenges.""

High formulation complexity remains an important restraint because specialized stem cell media may contain sensitive proteins, growth factors, cytokines, and other components requiring controlled handling. Quality and storage considerations influence approximately 24% of purchasing decisions in the supplied analysis. Laboratories must manage appropriate storage temperatures, preparation procedures, inventory rotation, and contamination prevention. Sensitive formulations can become unsuitable when handling conditions differ from manufacturer instructions. Smaller research organizations may face additional challenges because specialized storage and quality-control infrastructure can increase operating requirements. Suppliers are improving packaging, documentation, and product stability to address these concerns. Nevertheless, product complexity continues influencing purchasing and implementation decisions.

Raw-material availability creates another restraint because specialized culture media depend on dependable supplies of suitable nutrients and biologically active components. Hematopoietic Stem Cell Culture represents approximately 27% of the supplied product distribution and often requires carefully controlled growth-supporting conditions. Changes in raw-material quality or availability may influence manufacturing schedules and product consistency. Laboratories adopting alternative media must verify compatibility with established cellular protocols. Product qualification can require additional experiments and technical resources. Manufacturers increasingly prioritize supplier management, controlled manufacturing processes, and documented quality standards. Reliable distribution and technical support remain important for preventing interruptions to ongoing research activities.

Opportunity

""Specialized formulations and scalable manufacturing create new commercial opportunities.""

Expansion of pluripotent stem cell research creates opportunities for manufacturers developing defined formulations and advanced cell culture systems. Pluripotent Stem Cell Culture accounts for approximately 41% of the supplied product distribution, supporting continued product development. Researchers increasingly require media designed for specific cell populations and differentiation objectives. Manufacturers can strengthen their competitive position through improved growth-factor combinations, application-specific supplements, and reproducible performance. Ready-to-use formulations may reduce preparation complexity and support standardized laboratory procedures. Custom media development also provides opportunities for suppliers working with biotechnology companies. Continued research into regenerative medicine supports demand for specialized products and technical application services.

Industrial-scale stem cell production provides another opportunity as biotechnology organizations move selected cellular processes toward more standardized manufacturing environments. Industrial Production represents approximately 25% of the supplied application distribution. Larger culture systems require dependable media composition, consistent supply, and compatibility with automated processing equipment. Manufacturers are developing concentrated formulations, scalable packaging, and improved manufacturing controls to address these requirements. Technical services can help customers evaluate media performance before expanding production volumes. Quality documentation and lot traceability also support manufacturing readiness. Suppliers offering both specialized formulations and dependable production infrastructure can establish stronger relationships with advanced biotechnology developers.

Challenge

""Maintaining consistent stem cell performance across complex culture workflows remains challenging.""

Reproducibility remains a central challenge because stem cells can respond differently to variations in nutrient composition, passage conditions, environmental factors, and culture handling. Advanced defined media represent approximately 43% of newly evaluated culture workflows, reflecting increasing efforts to control experimental variability. Researchers must maintain suitable conditions during cell expansion and differentiation to support dependable outcomes. Even minor changes in formulation preparation may affect cellular characteristics. Manufacturers therefore require reliable raw-material controls, consistent production methods, and appropriate quality testing. Laboratories also need documented procedures and trained personnel to maintain comparable experimental conditions. Product reliability remains essential for complex cellular research.

Scaling established laboratory procedures into larger manufacturing systems creates additional challenges because culture conditions can change with vessel size and processing methods. Mesenchymal Stem Cell Culture represents approximately 22% of the supplied product distribution, illustrating the importance of scalable formulations for specialized cellular workflows. Larger systems may require different feeding schedules, mixing conditions, and nutrient-delivery approaches. Media performance must be evaluated under relevant production conditions before widespread adoption. Manufacturers increasingly invest in application support, formulation optimization, and technical documentation. Reliable supply-chain coordination is also important because industrial users depend on consistent product availability. Effective process development supports smoother transitions between laboratory research and commercial manufacturing.

Stem Cell Media Market Segmentation

Global Stem Cell Media Market Size, 2035

Get Comprehensive Insights on the Market Segmentation in this Report

download Download FREE Sample

By Types

Pluripotent Stem Cell Culture: Pluripotent Stem Cell Culture represents the leading product category because pluripotent cells are widely used in developmental research, disease modeling, and differentiation studies. The segment accounts for approximately 41% of the supplied product distribution. These cells require specialized nutritional and signaling environments to support controlled maintenance and expansion. Researchers increasingly prefer defined formulations that help preserve appropriate cellular characteristics across repeated passages. Media manufacturers are developing optimized nutrients, growth-supporting components, and simplified feeding protocols. Demand is strengthened by research programs investigating regenerative medicine and specialized cellular models. Manufacturers offering reproducible products and detailed application guidance can address growing laboratory requirements.

Hematopoietic Stem Cell Culture: Hematopoietic Stem Cell Culture supports research involving blood-forming cells, immune-system development, and specialized cellular investigations. This segment represents approximately 27% of the supplied product distribution. Media formulations require suitable nutrients and growth-supporting components to maintain desired cellular characteristics during experimental procedures. Researchers increasingly evaluate products according to viability, consistency, and compatibility with established culture protocols. Manufacturers are improving supplementation strategies, manufacturing controls, and technical documentation to address laboratory requirements. Growing interest in hematopoietic biology and advanced cellular technologies supports continued demand. Reliable media performance remains important when experiments involve multiple culture stages and complex downstream analysis.

Mesenchymal Stem Cell Culture: Mesenchymal Stem Cell Culture is important for research involving stromal cells, tissue-related investigations, and regenerative medicine development. The category represents approximately 22% of the supplied product distribution. Researchers require media capable of supporting cell expansion while maintaining suitable characteristics for downstream experiments. Serum-free and defined formulations are gaining attention because they can reduce certain sources of variability when properly validated. Manufacturers are improving growth performance, handling convenience, and formulation consistency. Research organizations also consider scalability as cellular programs progress toward larger processing volumes. Specialized technical support helps laboratories select appropriate formulations and evaluate compatibility with established culture procedures.

Other: The Other product category includes specialized stem cell formulations developed for emerging cellular models and experimental requirements outside the principal classifications. This segment accounts for approximately 10% of the supplied product distribution. Research organizations may require customized nutrients, growth-factor combinations, or specialized supplements for particular cellular objectives. Manufacturers are developing flexible formulation services and smaller packaging configurations to address niche applications. Product customization provides opportunities for suppliers capable of technical consultation and specialized manufacturing. Demand depends on the development of new cellular research approaches and the suitability of available media. Reliable quality control and appropriate documentation remain important for adoption.

By Applications

Scientific Research: Scientific Research represents the largest application category because universities, biotechnology laboratories, and research institutions extensively use stem cells in experimental investigations. The segment accounts for approximately 61% of the supplied application distribution. Researchers require specialized media for cellular expansion, differentiation, disease modeling, and developmental studies. Different experiments may involve distinct nutritional requirements and multiple culture stages. Manufacturers increasingly offer defined formulations, ready-to-use products, and technical guidance to improve reproducibility. Research laboratories also prioritize dependable product availability and batch consistency. Continued investment in regenerative medicine and advanced biological research supports recurring demand for specialized stem cell culture products.

Industrial Production: Industrial Production includes biotechnology manufacturing and structured cell-based processes requiring dependable culture conditions and scalable media supply. The segment represents approximately 25% of the supplied application distribution. Production organizations evaluate formulations according to consistency, quality documentation, packaging suitability, and compatibility with automated equipment. Larger manufacturing volumes can require controlled nutrient delivery and standardized feeding procedures. Suppliers are developing scalable formats and improved quality systems to support these requirements. Reliable manufacturing capacity and temperature-controlled distribution remain important commercial factors. Increasing investment in advanced cellular technologies creates opportunities for media manufacturers serving research-to-production transitions and specialized biotechnology operations.

Other: The Other application category includes specialized laboratory services, exploratory development programs, and emerging stem cell workflows outside Scientific Research and Industrial Production. The segment represents approximately 14% of the supplied application distribution. Organizations within this category may require customized formulations and flexible packaging arrangements for specialized cellular procedures. Product selection depends on experimental objectives, handling requirements, and compatibility with existing laboratory equipment. Manufacturers can address demand through modular supplements, technical assistance, and controlled manufacturing. Emerging applications may provide opportunities for new formulation development before wider commercial adoption. Dependable product consistency remains important across these diverse cellular workflows.

Stem Cell Media Market Regional Outlook

Global Stem Cell Media Market Share, by Type 2035

Get Comprehensive Insights into the Market’s Size and Growth Trends

download Download FREE Sample

North America

North America leads the Stem Cell Media Market through extensive biotechnology infrastructure, pharmaceutical development, academic research, and advanced therapeutic programs. The region represents approximately 36% of the supplied global market distribution. The United States contributes substantial demand through research universities, biotechnology companies, and specialized laboratories. Researchers increasingly use pluripotent, hematopoietic, and mesenchymal stem cell models for disease investigation and cellular development. Demand is supported by established laboratory supply networks and advanced research equipment. Manufacturers are prioritizing defined formulations, scalable media production, and technical support. Continued investment in regenerative medicine and cellular technologies strengthens the region's market position.

Europe

Europe maintains a significant Stem Cell Media Market supported by biotechnology development, academic research, pharmaceutical innovation, and regenerative medicine programs. The region accounts for approximately 29% of the supplied global market distribution. Germany, France, the United Kingdom, Switzerland, and other European countries contribute through specialized research institutes and biotechnology organizations. Laboratories increasingly prioritize chemically defined formulations and documented quality procedures. Stem cell research programs require reliable media for expansion, maintenance, and differentiation across different experimental stages. Manufacturers are improving technical support and supply reliability to address these requirements. Continued development of cell-based research and industrial biotechnology supports regional demand.

Asia-Pacific

Asia-Pacific represents an expanding Stem Cell Media Market as biotechnology investment, pharmaceutical research, and advanced laboratory infrastructure continue developing. The region accounts for approximately 25% of the supplied global market distribution. China, Japan, India, South Korea, Singapore, and other markets support demand through academic research and biotechnology manufacturing. Regional laboratories increasingly require specialized media for pluripotent and mesenchymal stem cell programs. Improvements in technical expertise and laboratory equipment are encouraging adoption of defined culture systems. Manufacturers are strengthening regional distribution, manufacturing capabilities, and technical services. Continued investment in regenerative medicine research and biotechnology infrastructure supports future opportunities.

Middle East and Africa

Middle East and Africa represents an emerging Stem Cell Media Market supported by investment in scientific research, biotechnology infrastructure, and specialized laboratory facilities. The region accounts for approximately 6% of the supplied global market distribution. Research organizations increasingly investigate advanced cellular technologies, creating demand for reliable culture products. Product availability, temperature-controlled storage, and technical expertise influence purchasing decisions. Suppliers offering application support and dependable distribution can improve market accessibility. Academic institutions and medical research centers remain important demand contributors. Continued laboratory modernization and development of specialized biotechnology programs provide opportunities for gradual market expansion.

Rest of the World

Rest of the World includes developing biotechnology markets where academic research and specialized cellular investigations are gradually expanding. The region represents approximately 4% of the supplied global market distribution. Latin American research institutions and biotechnology organizations contribute through stem cell studies, laboratory development, and emerging therapeutic research. Buyers evaluate media according to availability, storage stability, and compatibility with established procedures. Manufacturers can strengthen access through regional distributors, technical guidance, and suitable packaging formats. Growing research collaboration may increase demand for specialized formulations. Continued investment in scientific infrastructure supports gradual adoption of advanced stem cell culture media.

List of Top Stem Cell Media Companies

  • GE Healthcare
  • Merck Millipore
  • HiMedia
  • Lonza
  • STEMCELL Technologies
  • Takara
  • CellGenix
  • PromoCell
  • Miltenyi Biotec
  • Thermo Fisher
  • Corning

Top Two Companies with Highest Market Share

  • STEMCELL Technologies: STEMCELL Technologies holds an estimated 10% share of the Stem Cell Media Market, supported by its specialized culture formulations, extensive research applications, and established laboratory customer base.
  • Thermo Fisher: Thermo Fisher holds an estimated 9% share of the Stem Cell Media Market, supported by its Gibco culture media portfolio, advanced laboratory technologies, and broad biotechnology research presence.

Investment Analysis and Opportunities

Investment in the Stem Cell Media Market increasingly focuses on specialized formulations, manufacturing consistency, scalable production, and reliable supply chains. Pluripotent Stem Cell Culture represents approximately 41% of the supplied product distribution, highlighting its importance to research-focused investment. Manufacturers are developing chemically defined products, optimized growth-factor combinations, and improved quality-control systems. Research organizations increasingly require reliable media performance across extended cellular experiments. Investment in manufacturing technology can improve raw-material handling and consistency between production batches. Technical support and formulation development services provide additional commercial opportunities. Suppliers offering dependable products and scalable manufacturing capabilities can strengthen participation in advanced cellular research markets.

Industrial Production offers additional investment opportunities as biotechnology companies develop larger and more standardized cellular manufacturing systems. The application represents approximately 25% of the supplied market distribution, reflecting commercial demand for scalable culture formulations. Manufacturers are investing in production infrastructure, specialized packaging, quality documentation, and temperature-controlled distribution. Automation-compatible products can support more efficient dispensing and feeding processes when appropriately validated. Regional manufacturing partnerships may improve product availability and reduce supply disruptions. Custom media development also creates opportunities for suppliers working with specialized biotechnology programs. Long-term investment potential depends on formulation reliability, technical capabilities, and dependable manufacturing support.

New Product Development

New product development increasingly prioritizes chemically defined formulations, improved cell viability, and consistent differentiation performance. Advanced defined media represent approximately 43% of newly evaluated culture workflows in the supplied market analysis. Manufacturers are refining nutrient compositions, growth-factor combinations, and serum-free systems to address specialized research requirements. Pluripotent stem cell products remain important because researchers require media capable of supporting controlled expansion and differentiation. Product innovation also includes ready-to-use formulations and simplified preparation procedures. Improved manufacturing controls and quality documentation can reduce unnecessary variability. Suppliers increasingly develop products designed to perform reliably across different laboratory environments.

Customization and scalability represent additional product-development priorities as biotechnology organizations require specialized media for advanced cellular processes. Formulation customization influences approximately 27% of the supplied new-product evaluations. Manufacturers are developing tailored nutrient systems, concentrated supplements, and packaging formats suitable for different culture volumes. Automation-compatible formulations can support standardized laboratory processes and industrial production requirements. Media suppliers are also improving lot traceability and technical support. These innovations help researchers evaluate product performance across multiple culture stages. Continued investment in manufacturing readiness and application-specific development supports the evolution of specialized stem cell media products.

Five Recent Developments

  • January 2026 – Miltenyi Biotec: Miltenyi Biotec published its updated cell culture reagent portfolio, documenting specialized StemMACS media, supplements, and GMP-oriented culture products for stem cell and immune-cell applications. Pluripotent Stem Cell Culture represents approximately 41% of the supplied product distribution, reflecting demand for specialized formulations supporting advanced cellular research.
  • Winter 2026 – Corning: Corning highlighted its MSCulture Max media portfolio, including formulations developed to support mesenchymal stromal cell expansion, streamlined culture procedures, and scalable manufacturing applications. Mesenchymal Stem Cell Culture represents approximately 22% of the supplied product distribution, demonstrating the relevance of specialized expansion media for regenerative research.
  • March 2026 – Lonza: Lonza launched its Media Development Lab in Singapore, introducing formulation optimization services intended to improve cell culture performance, process robustness, and manufacturing scalability. Formulation customization influences approximately 27% of the supplied new-product evaluations, highlighting demand for tailored media development and dependable production workflows.
  • September 2026 – Thermo Fisher: Thermo Fisher expanded the commercial availability of its Gibco CHO-K1 Catalog Panel, providing chemically defined media and feed formulations for biotechnology process development and manufacturing. Industrial Production represents approximately 25% of the supplied application distribution, although this product addresses CHO-based biologics manufacturing rather than stem cell culture specifically.
  • October 2026 – Merck Millipore: Merck opened its Asia-Pacific Bioprocessing Production Center in Daejeon, South Korea, strengthening regional manufacturing capabilities for cell culture media and related bioprocessing materials. Asia-Pacific represents approximately 25% of the supplied regional market distribution, emphasizing the commercial importance of regional production capacity and dependable media supply chains.

Future Outlook of Stem Cell Media Market

The Stem Cell Media Market is expected to advance through continued regenerative medicine research, expanding biotechnology capabilities, and increasing use of specialized cellular models. Laboratories will increasingly prioritize reproducible formulations, chemically defined culture environments, and reliable cell performance across different experimental procedures. Pluripotent, hematopoietic, and mesenchymal stem cell applications will continue generating requirements for tailored nutrients and growth-supporting components. Manufacturers are expected to strengthen quality control, formulation development, and manufacturing scalability. Research organizations will also emphasize dependable supply chains and product documentation. Continued scientific innovation will support demand for specialized culture solutions across established and developing biotechnology markets.

Future market development will increasingly emphasize scalable production, automation compatibility, and application-specific formulation technology. Biotechnology companies will require media that support dependable cell expansion and consistent performance as selected processes move from laboratory research toward larger manufacturing environments. Suppliers will continue improving packaging, raw-material qualification, technical services, and distribution infrastructure. Customized media development may become more important as advanced cellular workflows require increasingly precise nutritional conditions. Regional biotechnology expansion will create additional opportunities for manufacturers offering reliable products and technical expertise. Long-term growth will depend on reproducibility, manufacturing quality, scientific innovation, and continued investment in advanced stem cell research.

Stem Cell Media Market Report Coverage

REPORT COVERAGE DETAILS

Market Size Value In

USD 545.14 Million in 2026

Market Size Value By

USD 1210.84 Million by 2035

Growth Rate

CAGR of 9.27% from 2026-2035

Forecast Period

2026 - 2035

Base Year

2025

Historical Data Available

Yes

Regional Scope

Global

Segments Covered

By Type :

  • Pluripotent Stem Cell Culture
  • Hematopoietic Stem Cell Culture
  • Mesenchymal Stem Cell Culture
  • Other

By Application :

  • Scientific Research
  • Industrial Production
  • Other

To Understand the Detailed Market Report Scope & Segmentation

download Download FREE Sample

Frequently Asked Questions

The global Stem Cell Media Market is expected to reach USD 1210.84 Million by 2035.

The Stem Cell Media Market is expected to exhibit a CAGR of 9.27% by 2035.

GE Healthcare,Merck Millipore,HiMedia,Lonza,STEMCELL Technologies,Takara,CellGenix,PromoCell,Miltenyi Biotec,Thermo Fisher,Corning are top companes of Stem Cell Media Market.

In 2025, the Stem Cell Media Market value stood at USD 498.9 Million.

faq right

Our Clients

Captcha refresh

Trusted & Certified